All-cause mortality risk of metabolically healthy obese individuals in NHANES III

Journal of Obesity

Volumn 2012, Issue , 2012, Pages

  Durward, C M ^a   Hartman, T J ^a   Nickols Richardson, S M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL; LIPID;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC BALANCE; METABOLIC SYNDROME X; MORTALITY; OBESITY; RISK FACTOR; BLOOD; CAUSE OF DEATH; METABOLISM; MIDDLE AGED; NUTRITION; PROPORTIONAL HAZARDS MODEL;

ADULT; CAUSE OF DEATH; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

MLCS; MLOWN;

EID: 84871841294     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2012/460321     Document Type: Article

References (87)

1. Bray G. A., Risks of obesity. Endocrinology and Metabolism Clinics of North America 2003 32 4 787 804 2-s2.0-0347993851 10.1016/S0889-8529(03)00067-7 (Pubitemid 38029981)
2. Bray G. A., Medical consequences of obesity. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2583 2589 2-s2.0-2942657650 10.1210/jc.2004-0535 (Pubitemid 38766335)
3. McLaughlin T., Sherman A., Tsao P., Gonzalez O., Yee G., Lamendola C., Reaven G. M., Cushman S. W., Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007 50 8 1707 1715 2-s2.0-34447130417 10.1007/s00125-007-0708-y (Pubitemid 47036653)
4. Primeau V., Coderre L., Karelis A. D., Brochu M., Lavoie M. E., Messier V., Sladek R., Rabasa-Lhoret R., Characterizing the profile of obese patients who are metabolically healthy. International Journal of Obesity 2011 35 7 971 981 2-s2.0-79960226240 10.1038/ijo.2010.216
5. Blüher M., The distinction of metabolically "healthy" from "unhealthy" obese individuals. Current Opinion in Lipidology 2010 21 1 38 43 2-s2.0-77649171169 10.1097/MOL.0b013e3283346ccc
6. Succurro E., Marini M. A., Frontoni S., Hribal M. L., Andreozzi F., Lauro R., Perticone F., Sesti G., Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity 2008 16 8 1881 1886 2-s2.0-48749105019 10.1038/oby.2008.308
7. Karelis A. D., St-Pierre D. H., Conus F., Rabasa-Lhoret R., Poehlman E. T., Metabolic and body composition factors in subgroups of obesity: What do we know? Journal of Clinical Endocrinology and Metabolism 2004 89 6 2569 2575 2-s2.0-2942657651 10.1210/jc.2004-0165 (Pubitemid 38766333)
8. Wildman R. P., Muntner P., Reynolds K., McGinn A. P., Rajpathak S., Wylie-Rosett J., Sowers M. R., The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Archives of Internal Medicine 2008 168 15 1617 1624 2-s2.0-49449106657 10.1001/archinte.168.15.1617
9. Manu P., Ionescu-Tirgoviste C., Tsang J., Napolitano B. A., Lesser M. L., Correll C. U., Dysmetabolic signals in "metabolically healthy" obesity. Obesity Research and Clinical Practice 2012 6 1 e9 e20 2-s2.0-79956016785 10.1016/j.orcp.2011.04.003
10. Kuk J. L., Ardern C. I., Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009 32 12 2297 2299 2-s2.0-72249111967 10.2337/dc09-0574
11. Bray G. A., Clearfield M. B., Fintel D. J., Nelinson D. S., Overweight and obesity: the pathogenesis of cardiometabolic risk. Clinical Cornerstone 2009 9 4 30 42 2-s2.0-70349319652 10.1016/S1098-3597(09)80003-3
12. Marini M. A., Succurro E., Frontoni S., Hribal M. L., Andreozzi F., Lauro R., Perticone F., Sesti G., Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 2007 30 8 2145 2147 2-s2.0-34547699606 10.2337/dc07-0419 (Pubitemid 47219439)
13. Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., Balletshofer B., Machicao F., Fritsche A., Häring H. U., Identification and characterization of metabolically benign obesity in humans. Archives of Internal Medicine 2008 168 15 1609 1616 2-s2.0-49449092403 10.1001/archinte.168. 15.1609
14. Meigs J. B., Wilson P. W. F., Fox C. S., Vasan R. S., Nathan D. M., Sullivan L. M., D'Agostino R. B., Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 2006 91 8 2906 2912 2-s2.0-33747739430 10.1210/jc.2006-0594 (Pubitemid 44271734)
15. St-Pierre A. C., Cantin B., Mauriège P., Bergeron J., Dagenais G. R., Després J. P., Lamarche B., Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. Canadian Medical Association Journal 2005 172 10 1301 1305 2-s2.0-19744368235 10.1503/cmaj.1040834 (Pubitemid 40745071)
16. Hosseinpanah F., Barzin M., Sheikholeslami F., Azizi F., Effect of different obesity phenotypes on cardiovascular events in Tehran lipid and glucose study (TLGS). American Journal of Cardiology 2011 107 3 412 416 2-s2.0-78951479474 10.1016/j.amjcard.2010.09.034
17. Voulgari C., Tentolouris N., Dilaveris P., Tousoulis D., Katsilambros N., Stefanadis C., Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. Journal of the American College of Cardiology 2011 58 13 1343 1350 10.1016/j.jacc.2011.04.047
18. Kip K. E., Marroquin O. C., Kelley D. E., Johnson B. D., Kelsey S. F., Shaw L. J., Rogers W. J., Reis S. E., Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004 109 6 706 713 2-s2.0-1242291791 10.1161/01.CIR.0000115514.44135.A8 (Pubitemid 38222888)
19. Ärnlöv J., Ingelsson E., Sundström J., Lind L., Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010 121 2 230 236 2-s2.0-74949084667 10.1161/CIRCULATIONAHA.109.887521
20. Stefan N., Fritsche A., Häring H. U., Letter by Stefan et al regarding article, 'impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men'. Circulation 2010 122 11 e456 2-s2.0-77957267812 10.1161/CIRCULATIONAHA.110.942276
21. Calori G., Lattuada G., Piemonti L., Garancini M. P., Ragogna F., Villa M., Mannino S., Crosignani P., Bosi E., Luzi L., Ruotolo G., Perseghin G., Prevalence, metabolic features, and prognosis of metabolically healthy obese italian individuals: the cremona study. Diabetes Care 2011 34 1 210 215 2-s2.0-79951694160 10.2337/dc10-0665
22. Ortega F. B., Lee D. C., Katzmarzyk P. T., The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. European Heart Journal. In press
23. Mason C., Katzmarzyk P. T., Blair S. N., Eligibility for obesity treatment and risk of mortality in men. Obesity Research 2005 13 10 1803 1809 2-s2.0-33644800214
24. Messier V., Karelis A. D., Prud'Homme D., Primeau V., Brochu M., Rabasa-Lhoret R., Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity 2010 18 5 911 917 2-s2.0-77951666576 10.1038/oby.2009.364
25. Shea J. L., Randell E. W., Sun G., The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity 2011 19 3 624 630 2-s2.0-79952006216 10.1038/oby.2010.174
26. Pataky Z., Makoundou V., Nilsson P., Gabriel R. S., Lalic K., Muscelli E., Casolaro A., Golay A., Bobbioni-Harsch E., Metabolic normality in overweight and obese subjects. Which parameters? Which risks? International Journal of Obesity 2011 35 1208 1215 2-s2.0-78650758734 10.1038/ijo.2010.264
27. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: program and collection procedures. Vital Health Statistics 1994 1 32 1 407
28. Richman E. L., Stampfer M. J., Editorial comment: weight loss and mortality in the elderly: Separating cause and effect. Journal of Internal Medicine 2010 268 2 103 105 2-s2.0-77954342679 10.1111/j.1365-2796.2010.02227.x
29. Karelis A. D., Brochu M., Rabasa-Lhoret R., Can we identify metabolically healthy but obese individuals (MHO)? Diabetes and Metabolism 2004 30 6 569 572 2-s2.0-11244269558 (Pubitemid 40070359)
30. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series 2000 894 1 253
31. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
32. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
33. Lee K., Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pacific Journal of Clinical Nutrition 2009 18 2 280 284 2-s2.0-70349567022
34. Bik W., Ostrowski J., Baranowska-Bik A., Wolinska-Witort E., Bialkowska M., Martynska L., Baranowska B., Adipokines and genetic factors in overweight or obese but metabolically healthy Polish women. Neuroendocrinology Letters 2010 31 4 497 506 2-s2.0-77957885442
35. Shin M. J., Hyun Y. J., Kim O. Y., Kim J. Y., Jang Y., Lee J. H., Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. International Journal of Obesity 2006 30 10 1529 1534 2-s2.0-33749126980 10.1038/sj.ijo.0803304 (Pubitemid 44470202)
36. Srdić B., Stokić E., Korać A., Ukropina M., Veliĉkovi K., Breberina M., Morphological characteristics of abdominal adipose tissue in normal-weight and obese women of different metabolic profiles. Experimental and Clinical Endocrinology and Diabetes 2010 118 10 713 718 2-s2.0-78349250617 10.1055/s-0030-1254165
37. Sundström J., Risérus U., Byberg L., Zethelius B., Lithell H., Lind L., Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. British Medical Journal 2006 332 7546 878 881 2-s2.0-33645969319 10.1136/bmj.38766.624097.1F (Pubitemid 44365581)
38. Karelis A. D., Messier V., Brochu M., Rabasa-Lhoret R., Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008 51 9 1752 1754 2-s2.0-49249132007 10.1007/s00125-008-1038-4
39. Perseghin G., Is a nutritional therapeutic approach unsuitable for metabolically healthy but obese women? Diabetologia 2008 51 9 1567 1569 2-s2.0-49249092202 10.1007/s00125-008-1077-x
40. Kantartzis K., Machann J., Schick F., Rittig K., Machicao F., Fritsche A., Häring H. U., Stefan N., Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 2011 54 4 864 868 2-s2.0-79953807628 10.1007/s00125-010-2006-3
41. McLaughlin T., Abbasi F., Lamendola C., Liang L., Reaven G., Schaaf P., Reaven P., Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002 106 23 2908 2912 2-s2.0-0037016001 10.1161/01.CIR.0000041046.32962.86 (Pubitemid 35424740)
42. Janiszewski P. M., Ross R., Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 2010 33 9 1957 1959 2-s2.0-79951659586 10.2337/dc10-0547
43. Sesti G., Folli F., Perego L., Hribal M. L., Pontiroli A. E., Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS One 2011 6 3 2-s2.0-79952411379 10.1371/journal.pone.0017737 e17737
44. Mann T., Tomiyama A. J., Westling E., Lew A. M., Samuels B., Chatman J., Medicare's search for effective obesity treatments: diets are not the answer. American Psychologist 2007 62 3 220 233 2-s2.0-34249285098 10.1037/0003-066X.62. 3.220
45. Graci S., Izzo G., Savino S., Cattani L., Lezzi G., Berselli M. E., Balzola F., Liuzzi A., Petroni M. L., Weight cycling and cardiovascular risk factors in obesity. International Journal of Obesity 2004 28 1 65 71 2-s2.0-0942279552 10.1038/sj.ijo.0802537 (Pubitemid 38141992)
46. Blair S. N., Shaten J., Brownell K., Collins G., Lissner L., Body weight change, all-cause mortality, and cause-specific mortality in the multiple risk factor intervention trial. Annals of Internal Medicine 1993 119 7, part 2 749 757 2-s2.0-0027443089 (Pubitemid 23313702)
47. Cherqaoui R., Kassim T. A., Kwagyan J., Freeman C., Nunlee-Bland G., Ketete M., Xu S., Randall O. S., The metabolically healthy but obese phenotype in African Americans. Journal of Clinical Hypertension 2012 14 2 92 96 10.1111/j.1751-7176.2011.00565.x
48. Khan U. I., Wang D., Thurston R. C., Sowers M., Sutton-Tyrrell K., Matthews K. A., Barinas-Mitchell E., Wildman R. P., Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN). Atherosclerosis 2011 217 1 179 186 2-s2.0-79958819452 10.1016/j.atherosclerosis.2011.01.007
49. Sesti G., Succurro E., Arturi F., Andreozzi F., Laino I., Perticone M., Sciacqua A., Hribal M. L., Perticone F., IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects. Nutrition, Metabolism and Cardiovascular Diseases 2010 21 12 933 940 2-s2.0-77955043384 10.1016/j.numecd.2010.02.008
50. Bouchard D. R., Langlois M. F., Brochu M., Dionne I. J., Baillargeon J. P., Metabolically healthy obese women and functional capacity. Metabolic Syndrome and Related Disorders 2011 9 3 225 229 2-s2.0-79957630827 10.1089/met.2010.0101
51. Brochu M., Tchernof A., Dionne I. J., Sites C. K., Eltabbakh G. H., Sims E. A. H., Poehlman E. T., What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? Journal of Clinical Endocrinology and Metabolism 2001 86 3 1020 1025 2-s2.0-0035052940 10.1210/jc.86.3.1020 (Pubitemid 32322976)
52. Dai X.-P., Liu Z.-Q., Xu L.-Y., Gong Z.-C., Huang Q., Dong M., Huang X., Association of plasma epinephrine level with insulin sensitivity in metabolically healthy but obese individuals. Autonomic Neuroscience 2012 167 1-2 66 69 10.1016/j.autneu.2011.10.006
53. Genelhu V. A., Celoria B. M. J., Duarte S. F. P., Cabello P. H., Francischetti E. A., Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2 diabetes. European Journal of Internal Medicine 2009 20 3 289 295 2-s2.0-67349180580 10.1016/j.ejim.2008.09. 009
54. Hayes L., Pearce M. S., Firbank M. J., Walker M., Taylor R., Unwin N. C., Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study. BMC Public Health 2010 10, article 723 2-s2.0-78549238912 10.1186/1471-2458-10-723
55. Karelis A. D., Faraj M., Bastard J. P., St-Pierre D. H., Brochu M., Prud'homme D., Rabasa-Lhoret R., The metabolically healthy but obese individual presents a favorable inflammation profile. Journal of Clinical Endocrinology and Metabolism 2005 90 7 4145 4150 2-s2.0-23044454515 10.1210/jc.2005-0482 (Pubitemid 41058189)
56. Klöting N., Fasshauer M., Dietrich A., Kovacs P., Schön M. R., Kern M., Stumvoll M., Blüher M., Insulin-sensitive obesity. American Journal of Physiology-Endocrinology and Metabolism 2010 299 3 E506 E515 2-s2.0-77956696547 10.1152/ajpendo.00586.2009
57. Krzyzanowska-Świniarska B., Kempa A., Miazgowski T., Pilarska K., Serum acylated ghrelin, adiponectin and leptin levels in normal-weight and obese premenopausal women. Hormone and Metabolic Research 2007 39 11 835 839 2-s2.0-36749097362 10.1055/s-2007-991175 (Pubitemid 350206908)
58. Messier V., Karelis A. D., Robillard M. È., Bellefeuille P., Brochu M., Lavoie J. M., Rabasa-Lhoret R., Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism 2010 59 1 20 24 2-s2.0-72049106119 10.1016/j.metabol.2009.06.020
59. Xu X. J., Gauthier M.-S., Hess D. T., Apovian C. M., Cacicedo J. M., Gokce N., Farb M., Valentine R. J., Ruderman N. B., Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. Journal of Lipid Research 2012 53 4 792 801 10.1194/jlr.P022905
60. Lynch L. A., O'Connell J. M., Kwasnik A. K., Cawood T. J., O'Farrelly C., O'Shea D. B., Are natural killer cells protecting the metabolically healthy obese patient? Obesity 2009 17 3 601 605 2-s2.0-60849138419 10.1038/oby.2008.565
61. O'Connell J., Lynch L., Cawood T. J., Kwasnik A., Nolan N., Geoghegan J., McCormick A., O'Farrelly C., O'Shea D., The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One 2010 5 4 2-s2.0-77956321989 10.1371/journal.pone.0009997 e9997
62. Koster A., Stenholm S., Alley D. E., Kim L. J., Simonsick E. M., Kanaya A. M., Visser M., Houston D. K., Nicklas B. J., Tylavsky F. A., Satterfield S., Goodpaster B. H., Ferrucci L., Harris T. B., Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity 2010 18 12 2354 2361 2-s2.0-78649955475 10.1038/oby.2010.86
63. Robillard M.-V., Bellefeuille P., Comtois A. S., Aubertin-Leheudre M., Karelis A. D., The metabolically healthy but obese postmenopausal woman presents a favourable heart rate variability profile. Scandinavian Cardiovascular Journal 2011 45 5 316 320 10.3109/14017431.2011.591818
64. Velho S., Paccaud F., Waeber G., Vollenweider P., Marques-Vidal P., Metabolically healthy obesity: different prevalences using different criteria. European Journal of Clinical Nutrition 2010 64 10 1043 1051 2-s2.0-77957852860 10.1038/ejcn.2010.114
65. Jennings C. L., Lambert E. V., Collins M., Joffe Y., Levitt N. S., Goedecke J. H., Determinants of insulin-resistant phenotypes in normal-weight and obese black african women. Obesity 2008 16 7 1602 1609 2-s2.0-46249087844 10.1038/oby.2008.233 (Pubitemid 351915104)
66. Chang Y., Ryu S., Suh B.-S., Yun K. E., Kim C.-W., Cho S.-I., Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. International Journal of Obesity 2012 36 9 1187 1194 10.1038/ijo.2011.247
67. Weiss R., Taksali S. E., Dufour S., Yeckel C. W., Papademetris X., Cline G., Tamborlane W. V., Dziura J., Shulman G. I., Caprio S., The "Obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. Journal of Clinical Endocrinology and Metabolism 2005 90 6 3731 3737 2-s2.0-21244444320 10.1210/jc.2004-2305 (Pubitemid 41014349)
68. Magkos F., Fabbrini E., Mohammed B. S., Patterson B. W., Klein S., Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity 2010 18 8 1510 1515 2-s2.0-79952201878
69. Fabbrini E., Magkos F., Mohammed B. S., Pietka T., Abumrad N. A., Patterson B. W., Okunade A., Klein S., Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proceedings of the National Academy of Sciences of the United States of America 2009 106 36 15430 15435 2-s2.0-70349326750 10.1073/pnas.0904944106
70. D'Adamo E., Cali A. M. G., Weiss R., Santoro N., Pierpont B., Northrup V., Caprio S., Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 2010 33 8 1817 1822 2-s2.0-77958180000 10.2337/dc10-0284
71. Kantartzis K., MacHann J., Schick F., Fritsche A., Häring H. U., Stefan N., The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia 2010 53 5 882 889 2-s2.0-77952095022 10.1007/s00125-010-1663-6
72. Calori G., Lattuada G., Ragogna F., Garancini M. P., Crosignani P., Villa M., Bosi E., Ruotolo G., Piemonti L., Perseghin G., Fatty liver index and mortality: the cremona study in the 15th year of follow-up. Hepatology 2011 54 1 145 152 2-s2.0-79959541652 10.1002/hep.24356
73. Perseghin G., Scifo P., de Cobelli F., Pagliato E., Battezzati A., Arcelloni C., Vanzulli A., Testolin G., Pozza G., Del Maschio A., Luzi L., Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999 48 8 1600 1606 2-s2.0-0032764784 10.2337/diabetes.48.8.1600 (Pubitemid 29356869)
74. Elisha B., Karelis A. D., Imbeault P., Rabasa-Lhoret R., Effects of acute hyperinsulinaemia on total and high-molecular-weight adiponectin concentration in metabolically healthy but obese postmenopausal women: a Montreal-Ottawa New Emerging Team (MONET) study. Diabetes and Metabolism 2010 36 4 319 321 2-s2.0-77956963825 10.1016/j.diabet.2010.03.004
75. Stefan N., Machicao F., Staiger H., Machann J., Schick F., Tschritter O., Spieth C., Weigert C., Fritsche A., Stumvoll M., Häring H. U., Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 2005 48 11 2282 2291 2-s2.0-27744492082 10.1007/s00125-005-1948-3 (Pubitemid 41618919)
76. Cameron A. J., Metabolically normal obesity: a misnomer? International Journal of Obesity 2012 36, article 164 2-s2.0-79952508357 10.1038/ijo.2011.57
77. McEvoy J. W., Blaha M. J., Nasir K., 'Metabolically benign' obesity: a wolf in sheep's clothing. Atherosclerosis 2011 217 1 74 76 2-s2.0-79960272211 10.1016/j.atherosclerosis.2011.02.039
78. Pataky Z., Bobbioni-Harsch E., Golay A., Open questions about metabolically normal obesity. International Journal of Obesity 2010 34 supplement 2 S18 S23 2-s2.0-78650128005 10.1038/ijo.2010.235
79. Blüher M., Adipose tissue dysfunction in obesity. Experimental and Clinical Endocrinology and Diabetes 2009 117 6 241 250 2-s2.0-68849132248 10.1055/s-0029-1192044
80. Bays H., Mandarino L., DeFronzo R. A., Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. Journal of Clinical Endocrinology and Metabolism 2004 89 2 463 478 2-s2.0-1442352339 10.1210/jc.2003-030723 (Pubitemid 38269844)
81. Okorodudu D. O., Jumean M. F., Montori V. M., Romero-Corral A., Somers V. K., Erwin P. J., Lopez-Jimenez F., Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. International Journal of Obesity 2010 34 5 791 799 2-s2.0-77952290167 10.1038/ijo.2010.5
82. Lee J. W., Lee H. R., Shim J. Y., Im J. A., Kim S. H., Choi H., Lee D. C., Viscerally obese women with normal body weight have greater brachial-ankle pulse wave velocity than nonviscerally obese women with excessive body weight. Clinical Endocrinology 2007 66 4 572 578 2-s2.0-33947210896 10.1111/j.1365-2265. 2007.02780.x (Pubitemid 46434946)
83. Robbins D. C., Andersen L., Bowsher R., Chance R., Dinesen B., Frank B., Gingerich R., Goldstein D., Widemeyer H. M., Haffner S., Hales C. N., Jarett L., Polonsky K., Porte D., Skyler J., Webb G., Gallagher K., Report of the American Diabetes Asociation's task force on standardization of the insulin assay. Diabetes 1996 45 2 242 256 2-s2.0-0030027254
84. Heinemann L., Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care-response to Staten et al. Diabetes Care 2010 33 6 e83 2-s2.0-77956090723 10.2337/dc10-0034
85. Sridhar M. S., Jarrett C. D., Xerogeanes J. W., Labib S. A., Obesity and symptomatic osteoarthritis of the knee. Journal of Bone and Joint Surgery B 2012 94 4 433 440 10.1302/0301-620X.94B4.27648
86. Karelis A. D., Fontaine J., Rabasa-Lhoret R., Prud'homme D., Doucet E., Blanchard C., Garrel D., Strychar I., Psychosocial profile of the metabolically healthy but obese postmenopausal woman. Diabetes and Metabolism 2006 32 1 90 91 2-s2.0-33646088383 10.1016/S1262-3636(07)70254-9 (Pubitemid 43872603)
87. Puhl R. M., Heuer C. A., Obesity stigma: important considerations for public health. American Journal of Public Health 2010 100 6 1019 1028 2-s2.0-77952251104 10.2105/AJPH.2009.159491